Lv1
4 积分 2023-08-03 加入
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study
1小时前
已完结
[China lymphoma diagnosis and treatment guideline (2026 edition)]
19天前
已完结
Light and shade of ruxolitinib: positive role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in patients with myelofibrosis
1个月前
已完结
Ultrasonography in the diagnosis of complications in patients with portal hypertension
1个月前
已完结
Drug-induced rise in serum creatinine: cystatin C to the rescue? Evidence, pitfalls and knowledge gaps
2个月前
已完结
JAK INHIBITOR INDUCED ANEMIA IN PEDIATRIC IBD
3个月前
已完结
药源性肾损害的诊治与预防
3个月前
已完结
An evaluation of elranatamab for the treatment of myeloma: current evidence for treating relapsed/refractory disease and future directions
3个月前
已完结
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
3个月前
已完结
皖公网安备34019202002308
